TB 2016 Posters - Saturday 16 July 2016
TB and HIV Co-infection: From Immune-pathogenesis to Integrated Care
P72 Perceived barriers and facilitators of isoniazid preventive therapy among HIV-infected pregnant women in South Africa.
P52 HIV prevalence, TB treatment outcomes and determinants of default in adolescents and young adults treated for TB in Cape Town.
P53 Outcomes of efavirenz- and non-efavirenz containing ART in HIV-positive patients co-infected with tuberculosis in Eastern Europe, Western Europe and Latin America.
P54 Self-reported adherence to antiretroviral therapy predicts subsequent retention in care for extensively drug resistant tuberculosis (XDR-TB) HIV co-infected patients on treatment in KwaZulu-Natal, South Africa.
P55 Plasma cytokine predictors of TB recurrence in HIV-infected individuals on ART in Durban, South Africa.
P56 Provider-initiated HIV counselling and testing for patients with presumptive tuberculosis in Mandalay General Hospital, Myanmar, 2014-2015.
P57 Mortality and associated factors in ART-naïve HIV-infected children with a suspicion of tuberculosis.
P59 Extensively drug resistant tuberculosis and HIV co-infection in KwaZulu-Natal, South Africa (the PROX study): treatment outcomes and molecular epidemiology.
P60 TB diagnosis with combined point-of-care tests in HIV+ patients in Mozambique.
P61 Challenges to the integration of HIV and M/XDR-TB services in South Africa: a qualitative study of frontline health providers.
P81 Intensified tuberculosis case-finding among people living with HIV under integrated HIV care program in upper Myanmar, 2015.
P82 The evolution of Mycobacterium tuberculosis in HIV co-infected individuals in an HIV/TB endemic setting.
O21 High-dose rifampicin tuberculosis treatment regimen to reduce 12-month mortality of TB/HIV co-infected patients: The RAFA trial results.
Implementation Science: Delivering Interventions to TB and its Co-morbidities (Diabetes, Alcohol, Malnutrition, Tobacco)
P17 Opportunity to reduce pre-diagnosis attrition among patients with presumptive MDR-TB in Bhopal district, India: an operational research.
P18 “Finding” TB in India via active pharmacy engagement: early results from the IC-IMPACTS study.
P19 Use of GeneXpert and household-based TB screening for detecting MDR TB in HIV-positive clients in two communities in Lusaka, Zambia during HPTN 071 (PopART study).
P20 Does level of access to healthcare predict loss to follow-up among tuberculosis patients? A multilevel study.
P21 Intervention for patients interrupting rifampicin-resistant tuberculosis treatment for greater than two weeks: a descriptive analysis from Khayelitsha, South Africa.
P22 Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults.
P23 Timing of contact tracing of household members of tuberculosis cases for optimal yield and resource allocation.
P25 Access to second-line treatment for children diagnosed with rifampicin-resistant tuberculosis in South Africa: a national retrospective cohort study.
P27 Screening for active TB in a diabetes mellitus clinic in Soweto, South Africa.
P28 Improving TB treatment outcomes in Matlosana and Ventersdorp sub-districts, Dr Kenneth Kaunda District, 2009 to 2014.
P29 Self-administered treatment for the continuation phase of rifampicin-resistant tuberculosis treatment: feasibility and impact on patient outcomes in Khayelitsha, South Africa.
P30 Universal Access to TB Care (UATBC): information technology platform to drive scale up in private sector engagement.
P31 Prevalence of and risk factors for diabetes mellitus among pulmonary tuberculosis patients in Pune, India.
P32 “Keeping-up with the DOTS”: patients’ perspectives of a financial incentive intervention to improve
tuberculosis care: a qualitative study.
Measuring the TB Epidemic: What is the best Method? (Prevalence Surveys and Programmatic Implications)
P73 Autopsy prevalence of TB and other infections in adults with advanced HIV enrolled in out-patient care in South Africa.
P33 The childhood tuberculosis care cascade in HIV infected and uninfected children living in rural Uganda and Kenya.
P34 Prevalence of latent TB infection among adults in endemic regions screened for a phase2b, double-blind, randomized, placebo-controlled study to evaluate GSK candidate vaccine M72/AS01E (NCT01755598).
Advances in Understanding the Basic Biology of TB
P71 Metabolomics - identifying small tuberculosis biomarkers with big implications.
P74 Global transcriptional profiling elucidates significant up- regulation of host cytokines, chemokines and chemokine receptors by heparin binding hemagglutinin adhesin in BALB/c mice lungs.
P75 Prevalence of inhA and KatG mutations and associated treatment outcomes among persons with multidrug resistant tuberculosis in Khayelitsha, South Africa.
P03 Unvisited players of eicosanoid pathway in Mycobacterium tuberculosis infection: cysteinyl leukotrienes.
P04 Whole transcriptome analysis to elucidate the role of M. tuberculosis curli pili (MTP) on host gene regulation in a pulmonary epithelial cell model.
P05 Growth of Mycobacterium tuberculosis in dead macrophages drives a host cell death cascade.
P76 Investigating the cost of rifampicin-resistance in mycobacteria.